Brokerages Set Fresenius Medical Care AG & Co. (FMS) Target Price at $62.00

Fresenius Medical Care AG & Co. (NYSE:FMS) has earned an average recommendation of “Buy” from the nine brokerages that are covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $60.00.

Several equities research analysts have commented on the stock. Zacks Investment Research lowered shares of Fresenius Medical Care AG & Co. from a “buy” rating to a “hold” rating in a report on Tuesday, January 23rd. SunTrust Banks set a $62.00 price target on shares of Fresenius Medical Care AG & Co. and gave the company a “buy” rating in a report on Thursday, December 21st. Nord/LB reaffirmed a “buy” rating on shares of Fresenius Medical Care AG & Co. in a report on Tuesday, January 2nd. DZ Bank reaffirmed a “buy” rating on shares of Fresenius Medical Care AG & Co. in a report on Monday, November 13th. Finally, Royal Bank of Canada reaffirmed a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a report on Tuesday, February 27th.

How to Become a New Pot Stock Millionaire

A number of large investors have recently bought and sold shares of FMS. UBS Asset Management Americas Inc. boosted its holdings in Fresenius Medical Care AG & Co. by 3.6% in the second quarter. UBS Asset Management Americas Inc. now owns 2,357 shares of the company’s stock valued at $114,000 after purchasing an additional 81 shares during the last quarter. Avestar Capital LLC purchased a new stake in Fresenius Medical Care AG & Co. in the fourth quarter valued at $115,000. SeaCrest Wealth Management LLC purchased a new stake in Fresenius Medical Care AG & Co. in the fourth quarter valued at $153,000. Millie Capital Management LLC purchased a new stake in Fresenius Medical Care AG & Co. in the fourth quarter valued at $203,000. Finally, HL Financial Services LLC purchased a new stake in Fresenius Medical Care AG & Co. in the fourth quarter valued at $215,000. 2.40% of the stock is currently owned by institutional investors.

Shares of Fresenius Medical Care AG & Co. (NYSE FMS) traded up $0.26 on Tuesday, hitting $52.64. 91,860 shares of the stock were exchanged, compared to its average volume of 145,482. The stock has a market capitalization of $32,263.27, a price-to-earnings ratio of 22.99, a PEG ratio of 1.88 and a beta of 0.59. The company has a quick ratio of 0.96, a current ratio of 1.20 and a debt-to-equity ratio of 0.54. Fresenius Medical Care AG & Co. has a 12-month low of $41.18 and a 12-month high of $57.94.

Fresenius Medical Care AG & Co. (NYSE:FMS) last announced its quarterly earnings data on Monday, February 26th. The company reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.61 by $0.08. The firm had revenue of $5.22 billion for the quarter, compared to analyst estimates of $5.37 billion. Fresenius Medical Care AG & Co. had a net margin of 7.23% and a return on equity of 11.64%. equities research analysts forecast that Fresenius Medical Care AG & Co. will post 2.86 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Brokerages Set Fresenius Medical Care AG & Co. (FMS) Target Price at $62.00” was originally posted by Markets Daily and is owned by of Markets Daily. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.themarketsdaily.com/2018/03/12/brokerages-set-fresenius-medical-care-ag-co-fms-target-price-at-62-00.html.

Fresenius Medical Care AG & Co. Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Analyst Recommendations for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply